These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20522628)

  • 1. Septic pneumonic tularaemia caused by Francisella tularensis subsp. holarctica biovar II.
    Fritzsch J; Splettstoesser WD
    J Med Microbiol; 2010 Sep; 59(Pt 9):1123-1125. PubMed ID: 20522628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
    J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the Subspecies of Francisella tularensis Isolated in Turkey by Molecular Methods].
    Çelebi B; Bakkaloğlu Z; Ünaldı Ö; Karagöz A; Kılıç S; Durmaz R
    Mikrobiyol Bul; 2020 Jan; 54(1):1-10. PubMed ID: 32050874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    Caspar Y; Hennebique A; Maurin M
    J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Diversity and Spatial Segregation of
    Appelt S; Köppen K; Radonić A; Drechsel O; Jacob D; Grunow R; Heuner K
    Front Cell Infect Microbiol; 2019; 9():376. PubMed ID: 31781515
    [No Abstract]   [Full Text] [Related]  

  • 6. Myositis and septicaemia caused by Francisella tularensis biovar holarctica.
    Eliasson H; Bäck E
    Scand J Infect Dis; 2003; 35(8):510-1. PubMed ID: 14514156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey.
    Yesilyurt M; Kiliç S; Celebi B; Celik M; Gül S; Erdogan F; Ozel G
    J Antimicrob Chemother; 2011 Nov; 66(11):2588-92. PubMed ID: 21856791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.
    Caspar Y; Sutera V; Boisset S; Denis JN; Maurin M
    Front Cell Infect Microbiol; 2014; 4():24. PubMed ID: 24579066
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Caspar Y; Maurin M
    Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
    Georgi E; Schacht E; Scholz HC; Splettstoesser WD
    J Antimicrob Chemother; 2012 Oct; 67(10):2429-33. PubMed ID: 22763567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First isolation of Francisella tularensis subsp. tularensis in Europe.
    Gurycová D
    Eur J Epidemiol; 1998 Dec; 14(8):797-802. PubMed ID: 9928875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report of Low Virulence Francisella tularensis Presented as Severe Bacteremic Pneumonia.
    Su TY; Shie SS; Chia JH; Huang CT
    Medicine (Baltimore); 2016 May; 95(19):e3390. PubMed ID: 27175638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013.
    Origgi FC; Frey J; Pilo P
    Euro Surveill; 2014 Jul; 19(29):. PubMed ID: 25080140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Francisella tularensis and tularemia in Turkey].
    Gürcan S
    Mikrobiyol Bul; 2007 Oct; 41(4):621-36. PubMed ID: 18173084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and genotyping of strains of Francisella tularensis isolated in Bulgaria.
    Marinov KT; Georgieva ED; Ivanov IN; Kantardjiev TV
    J Med Microbiol; 2009 Jan; 58(Pt 1):82-85. PubMed ID: 19074656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure.
    Sutera V; Hoarau G; Renesto P; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2017 Sep; 50(3):377-383. PubMed ID: 28689870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonic tularaemia: experience of 58 cases from 2000 to 2012 in Northern Finland.
    Väyrynen SA; Saarela E; Henry J; Lahti S; Harju T; Kauma H
    Infect Dis (Lond); 2017 Oct; 49(10):758-764. PubMed ID: 28618894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic markers for differentiation of Francisella tularensis subsp. tularensis A.I and A.II strains.
    Molins-Schneekloth CR; Belisle JT; Petersen JM
    Appl Environ Microbiol; 2008 Jan; 74(1):336-41. PubMed ID: 18024683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Francisella tularensis biovar palaearctica from human blood.
    Tärnvik A; Henning C; Falsen E; Sandström G
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):146-50. PubMed ID: 2498098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Francisella tularensis subspecies holarctica in China.
    Wang YH; Qiao FY; Cao J; Peng Y; Li H; Xia LX; Hai R
    Ticks Tick Borne Dis; 2015 Sep; 6(6):802-4. PubMed ID: 26210091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.